Glutathione-Depleting Pro-Oxidant as a Selective Anticancer Therapeutic Agent
نویسندگان
چکیده
منابع مشابه
Targets of 3-bromopyruvate, a new, energy depleting, anticancer agent.
3-bromopyruvate (3-BrPA), a pyruvate analog recently proposed as a possible anticancer drug, was investigated in relation to its capacity to inhibit energy production in fractions obtained from normal cells (rat hepatocytes) and in isolated rat thymocytes . Findings were that main targets of the drug were glyceraldehyde 3-phosphate dehydrogenase, and not hexokinase as suggested for hepatoma cel...
متن کاملPro-oxidant shift in glutathione redox state during aging.
The GSH:GSSG ratio, which is the primary determinant of the cellular redox state, becomes progressively more pro-oxidizing during the aging process due to an elevation in the GSSG content and a decline in the ability for de novo GSH biosynthesis. The K(m) of glutamate-cysteine ligase (GCL), the rate-limiting enzyme in de novo GSH biosynthesis, significantly increases during aging, which would a...
متن کاملPodophyllotoxin: a novel potential natural anticancer agent
Objective: The aim of the present review is to give an overview about the role, biosynthesis, and characteristics of Podophyllotoxin (PTOX) as a potential antitumor agent with particular emphasis on key biosynthesis processes, function of related enzymes and characterization of genes encoding the enzymes. Materials and Methods: Google scholar, PubMed and Scopus were searched for literatures wh...
متن کاملResveratrol as an antioxidant and pro-oxidant agent: mechanisms and clinical implications.
Resveratrol (3,4',5-trihydroxystilbene) is found in various plants, including grapes, berries and peanuts. It is also present in wines, especially red wines. During the last years, it has been the focus of numerous in vitro and in vivo studies investigating its biological attributes, which include mainly antioxidant and anti-inflammatory activities, anti-platelet aggregation effect, anti-athero...
متن کاملRunaway ROS as a selective anticancer strategy.
The majority of cancer therapies target macromolecules important for general cell survival, such as DNA, topoisomerase, and tubulin (e.g. , cisplatin, doxorubicin, and paclitaxel, respectively). While these agents are effective at killing many types of cancer cells, they also affect rapidly dividing normal cells, such as the intestinal lining and bone marrow, resulting in dose limiting toxiciti...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: ACS Omega
سال: 2019
ISSN: 2470-1343,2470-1343
DOI: 10.1021/acsomega.9b00140